Little Green Pharma Ltd (ASX: LGP) is pleased to announce its wholly owned subsidiary has entered into an agreement with Cannamedical® Pharma GmbH for the bulk supply of a high-THC strain into Germany.
- LGP partners with German cannabis pioneer Cannamedical for the supply of bulk medicinal cannabis from Denmark to Germany, with a potential value of over $4.5 million (€3 million) over two years
- LGP now has medicinal cannabis supply agreements with four key wholesalers and distributors in Germany, including three of the four largest independent, own-brand medicinal cannabis distributors in the country
- Agreement extends LGP’s lead as the pre-eminent non-Canadian global medicinal cannabis group supplying products into Germany and the EU
- Agreement represents continued validation of LGP’s key strategy of developing bespoke, high-value white label strains for export to lucrative jurisdictions
This agreement represents LGP’s fourth contract for the supply of medicinal cannabis into Germany and, together with Four20 Pharma, Illios Sante and Demecan, rounds out its wholesaling portfolio with the largest independent, own-brand medicinal cannabis distributor in Germany.
Cannamedical is a German-based pharmaceutical pioneer with licenses to import medicinal cannabis into Germany and distribute and export it within the European Union.
For more information please see the LGP Investor Centre